Digital Dose Inhaler Market

Digital Dose Inhaler Market by Product Types (Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI)), Applications (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), End-users (Hospital and Clinics), and Regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1475
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 187
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global digital dose inhaler market size is anticipated to reach USD 5.2 Billion by 2028, expanding at a CAGR of 12.7% during the forecast period, 2021–2028. The growth of the market is attributed to the increasing technological advancements and extensive use of smart computing devices. 


Digital Dose Inhaler Market summary

Digital dose inhalers are devices that help to provide a particular quantity of medication to the lungs and the drug gets self-administered by patients through inhalation. These devices consist of a pressurized canister that helps to release medication into the human body. Digital dose inhaler also helps patients to track the number of doses consumed as well as control the quantity of the doses digitally due to the built-in sensors.

Allergy spray, digihalers, pump or puffer are some alternative names of digital dose inhaler. These devices are utilized in the treatment and medication delivery of respiratory diseases including chronic obstructive pulmonary disease (COPD) and asthma.  Digital dose Inhalers reduce medication deposition in throat or mouth and also minimizes the requirement for coordination with actuation of the medical device. It provides access to the user as it can connect through Bluetooth to their mobile phone.

Electronic health records (EHRs) and electronic medical records (EMRs) are parts of digital dose inhaler, which are considered advantage to the modern health information technology. Some of the devices possess advanced features that detect inhaler use and also transmit required data.

Market Drivers, Restraints, Trends, and Opportunities

  • Growing awareness regarding the benefits of digital dose inhaler market in combination with respiratory medication systems is estimated to boost the market growth.
  • Increasing monitoring and management of respiratory diseases are boosting the global digital dose inhalers market growth in coming years.
  • Rising predominant factors of respiratory diseases such as COPD and asthma are expected to push the market growth during the forecast period.
  • Rising adoption of artificial intelligence (AI) and machine learning (MI) is expected to fuel the market growth.
  • High cost of treatments and respiratory inhalers can hinder the market growth.
  • Use of digital dose inhaler requires accurate information on various factors, which includes patient compliance and maintenance, and overdose which can restrict the market growth.

Scope of the Report

The report on the global digital dose inhaler market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Digital Dose Inhaler Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Type (Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI)),  Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others),and  End-users(Hospital and and Clinics)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Glenmark Pharmaceuticals Ltd., AstraZeneca Pl, Novartis International AG, Propeller Health, Philips Respironics, Opko Health, Inc., Teva Pharmaceutical Industries Ltd, Koninklijke Philips N.V., Sensirion AG Switzerland, and H&T Presspart Manufacturing Ltd.

Digital Dose Inhaler Market Segment Insights

Dry powder inhaler segment to account a major market share

Based on types the market is bifurcated into metered dose inhaler (MDI) and dry powder inhaler (DPI). The DPI segment is expected to account for a major market share due to rising occurrence of chronic respiratory diseases, such as COPD and asthma. Moreover, growing demand for technological attributes of respiratory devices is driving the segment growth. The existence of propellant components, such as chlorofluorocarbons (CFCs) causes drug irritation problems in MDI. This problem is overcome by usage of the DPI, with less irritant impacts.  


Digital Dose Inhaler Market types

Asthma segment is expected to grow at a significant pace

On the basis of applications, the market is segmented into asthma, COPD, and others. The asthma segment is anticipated to expand at a rapid pace during the forecast period owing to rising incidence of respiratory diseases. According to World Health Organization (WHO), around 269 Million people were affected with asthma.


Digital Dose Inhaler Market application

Hospital segment to exhibit a high CAGR

In terms of end-users the market is bifurcated into hospital and clinics. The hospital segment is expected to exhibit a high CAGR during forecast period. Patients prefer to visit hospitals due the presence of medical professionals and technology. However, the clinics segment is estimated to expand at a healthy rate owing to the rising number of clinics catering to breathing related ailments.


Digital Dose Inhaler Market end-users

North America projected to dominate the market

Based on regions, the market is divided into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market share during forecast period due to increasing geriatric population. Furthermore, the digital dose inhalers market in Asia Pacific is projected to expand at a rapid pace during the forecast period owing to the spread of respiratory diseases, growing urbanization, and increasing pollution and allergens.


Digital Dose Inhaler Market region

Segments

Segments Covered in the Report
The global digital dose inhaler market has been segmented on the basis of
Types

  • Metered Dose Inhaler (MDI)
  • Dry powder inhaler (DPI)

Applications

  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Others

 End-Users

  • Hospital
  • Clinics

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Glenmark Pharmaceuticals Ltd.
  • AstraZeneca Pl
  • Novartis AG
  • Propeller Health
  • Philips Respironics
  • Opko Health, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Koninklijke Philips N.V.
  • Sensirion AG Switzerland
  • H&T Presspart Manufacturing Ltd.

Competitive Landscape

Key players competing in the digital dose inhaler market include Glenmark Pharmaceuticals Ltd., AstraZeneca Pl, Novartis International AG, Propeller Health, Philips Respironics, Opko Health, Inc., Teva Pharmaceutical Industries Ltd, Koninklijke Philips N.V., Sensirion AG Switzerland, and H&T Presspart Manufacturing Ltd.

Digital Dose Inhaler Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Digital Dose Inhaler Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Digital Dose Inhaler Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Digital Dose Inhaler Market - Supply Chain
  4.5. Global Digital Dose Inhaler Market Forecast
     4.5.1. Digital Dose Inhaler Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Digital Dose Inhaler Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Digital Dose Inhaler Market Absolute $ Opportunity
5. Global Digital Dose Inhaler Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Digital Dose Inhaler Market Size and Volume Forecast by Types
     5.3.1. Metered Dose Inhaler (MDI)
     5.3.2. Dry powder inhaler (DPI)
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Digital Dose Inhaler Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Digital Dose Inhaler Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Digital Dose Inhaler Demand Share Forecast, 2019-2026
7. North America Digital Dose Inhaler Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Digital Dose Inhaler Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Digital Dose Inhaler Market Size and Volume Forecast by Types
     7.4.1. Metered Dose Inhaler (MDI)
     7.4.2. Dry powder inhaler (DPI)
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Digital Dose Inhaler Demand Share Forecast, 2019-2026
8. Latin America Digital Dose Inhaler Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Digital Dose Inhaler Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Digital Dose Inhaler Market Size and Volume Forecast by Types
     8.4.1. Metered Dose Inhaler (MDI)
     8.4.2. Dry powder inhaler (DPI)
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Digital Dose Inhaler Demand Share Forecast, 2019-2026
9. Europe Digital Dose Inhaler Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Digital Dose Inhaler Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Digital Dose Inhaler Market Size and Volume Forecast by Types
     9.4.1. Metered Dose Inhaler (MDI)
     9.4.2. Dry powder inhaler (DPI)
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Digital Dose Inhaler Demand Share Forecast, 2019-2026
10. Asia Pacific Digital Dose Inhaler Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Digital Dose Inhaler Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Digital Dose Inhaler Market Size and Volume Forecast by Types
     10.4.1. Metered Dose Inhaler (MDI)
     10.4.2. Dry powder inhaler (DPI)
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Digital Dose Inhaler Demand Share Forecast, 2019-2026
11. Middle East & Africa Digital Dose Inhaler Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Digital Dose Inhaler Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Digital Dose Inhaler Market Size and Volume Forecast by Types
     11.4.1. Metered Dose Inhaler (MDI)
     11.4.2. Dry powder inhaler (DPI)
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Digital Dose Inhaler Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Digital Dose Inhaler Market: Market Share Analysis
  12.2. Digital Dose Inhaler Distributors and Customers
  12.3. Digital Dose Inhaler Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Glenmark Pharmaceuticals Ltd.
     12.4.2. AstraZeneca Pl
     12.4.3. Novartis AG
     12.4.4. Propeller Health
     12.4.5. Philips Respironics
     12.4.6. Opko Health, Inc.
     12.4.7. Teva Pharmaceutical Industries Ltd.

Segments Covered in the Report
The global digital dose inhaler market has been segmented on the basis of
Types

  • Metered Dose Inhaler (MDI)
  • Dry powder inhaler (DPI)

Applications

  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Others

 End-Users

  • Hospital
  • Clinics

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Glenmark Pharmaceuticals Ltd.
  • AstraZeneca Pl
  • Novartis AG
  • Propeller Health
  • Philips Respironics
  • Opko Health, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Koninklijke Philips N.V.
  • Sensirion AG Switzerland
  • H&T Presspart Manufacturing Ltd.

Key players competing in the digital dose inhaler market include Glenmark Pharmaceuticals Ltd., AstraZeneca Pl, Novartis International AG, Propeller Health, Philips Respironics, Opko Health, Inc., Teva Pharmaceutical Industries Ltd, Koninklijke Philips N.V., Sensirion AG Switzerland, and H&T Presspart Manufacturing Ltd.

Digital Dose Inhaler Market keyplayers

Buy Report